BACKGROUND: The heart rate increase during exercise (DeltaHR) and heart rate recovery (HRR) have demonstrated prognostic value in several investigations, but its application in the heart failure (HF) population is limited, particularly in a beta-blocked (BB) cohort. METHODS: Five-hundred and twenty subjects with HF underwent cardiopulmonary exercise testing to determine peak oxygen consumption (VO(2)), the minute ventilation/carbon dioxide production (VE/VCO(2)) slope, DeltaHR and HRR at 1 min (HRR(1)). RESULTS: There were 79 cardiac-related deaths during the tracking period. A HRR(1) threshold of </>or=16 beats/min was a significant prognostic marker in the overall group (hazard ratio: 4.6, 95% CI: 2.8-7.5, p<0.001) as well as no-BB (hazard ratio: 9.1, 95% CI: 4.1-20.2, p<0.001) and BB (hazard ratio: 2.9, 95% CI: 1.6-5.4, p<0.001) subgroups. The DeltaHR was a significant univariate predictor in the overall group and no-BB subgroup only. Multivariate Cox regression analysis revealed HRR(1) was the strongest prognostic marker (chi-square: 39.9, p<0.001). The VE/VCO(2) slope (residual chi-square: 21.8, p<0.001) and LVEF (residual chi-square: 9.6, p=0.002) were also retained in the regression. CONCLUSIONS: These results indicate that HRR maintains prognostic value in HF irrespective of BB use. The routine inclusion of HRR in the prognostic assessment of patients with HF may be warranted. Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.
BACKGROUND: The heart rate increase during exercise (DeltaHR) and heart rate recovery (HRR) have demonstrated prognostic value in several investigations, but its application in the heart failure (HF) population is limited, particularly in a beta-blocked (BB) cohort. METHODS: Five-hundred and twenty subjects with HF underwent cardiopulmonary exercise testing to determine peak oxygen consumption (VO(2)), the minute ventilation/carbon dioxide production (VE/VCO(2)) slope, DeltaHR and HRR at 1 min (HRR(1)). RESULTS: There were 79 cardiac-related deaths during the tracking period. A HRR(1) threshold of </>or=16 beats/min was a significant prognostic marker in the overall group (hazard ratio: 4.6, 95% CI: 2.8-7.5, p<0.001) as well as no-BB (hazard ratio: 9.1, 95% CI: 4.1-20.2, p<0.001) and BB (hazard ratio: 2.9, 95% CI: 1.6-5.4, p<0.001) subgroups. The DeltaHR was a significant univariate predictor in the overall group and no-BB subgroup only. Multivariate Cox regression analysis revealed HRR(1) was the strongest prognostic marker (chi-square: 39.9, p<0.001). The VE/VCO(2) slope (residual chi-square: 21.8, p<0.001) and LVEF (residual chi-square: 9.6, p=0.002) were also retained in the regression. CONCLUSIONS: These results indicate that HRR maintains prognostic value in HF irrespective of BB use. The routine inclusion of HRR in the prognostic assessment of patients with HF may be warranted. Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.
Authors: Rhenan Bartels; Eliza Prodel; Mateus C Laterza; Jorge Roberto P de Lima; Tiago Peçanha Journal: Ann Noninvasive Electrocardiol Date: 2017-12-08 Impact factor: 1.468
Authors: Diana F Serapiao-Moraes; Vanessa Souza-Mello; Marcia B Aguila; Carlos A Mandarim-de-Lacerda; Tatiane S Faria Journal: Eur J Nutr Date: 2013-01-05 Impact factor: 5.614
Authors: Luiz Eduardo Ritt; Ricardo Brandão Oliveira; Jonathan Myers; Ross Arena; Mary Ann Peberdy; Daniel Bensimhon; Paul Chase; Daniel Forman; Marco Guazzi Journal: J Cardiopulm Rehabil Prev Date: 2012 May-Jun Impact factor: 2.081
Authors: Alexandra Zavin; Ross Arena; Jacob Joseph; Kelly Allsup; Karla Daniels; P Christian Schulze; Stewart Lecker; Daniel E Forman Journal: Eur J Prev Cardiol Date: 2012-04-19 Impact factor: 7.804
Authors: Lawrence P Cahalin; Daniel E Forman; Paul Chase; Marco Guazzi; Jonathan Myers; Daniel Bensimhon; Mary Ann Peberdy; Euan Ashley; Erin West; Ross Arena Journal: Int J Cardiol Date: 2013-02-04 Impact factor: 4.164
Authors: Stuart A Best; Tiffany B Bivens; M Dean Palmer; Kara N Boyd; M Melyn Galbreath; Yoshiyuki Okada; Graeme Carrick-Ranson; Naoki Fujimoto; Shigeki Shibata; Jeffrey L Hastings; Matthew D Spencer; Takashi Tarumi; Benjamin D Levine; Qi Fu Journal: J Appl Physiol (1985) Date: 2014-10-09